# Dr Aayush Gupta: clinical trials

> Dr Aayush Gupta, Professor and Head, Department of Dermatology, Venereology and Leprology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune. Source: https://aayushgupta.co/trials (updated 2026-10-15).

Dr Gupta is the principal investigator on all seven, for sponsors that include Johnson & Johnson, Pfizer, Sun Pharma and Ahammune Biosciences.

## Severe alopecia areata in adolescents: Deuruxolitinib
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a placebo-controlled study of deuruxolitinib in severe alopecia areata in adolescents, sponsored by Sun Pharma. Status: submitted to DCGI.
Official title: A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients with Severe Alopecia Areata with an Open-Label Extension Period
Page: https://aayushgupta.co/trials/deuruxolitinib-alopecia-areata-adolescents

## Multibacillary leprosy, treatment monitoring: Skin assessment chart and plasma PGL-I
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a phase 0 study of skin assessment chart and plasma PGL-I in multibacillary leprosy, treatment monitoring, sponsored by Johnson & Johnson. Status: opens October 2026.
Official title: A Phase 0, Clinical Study to Provide Fit-For-Purpose Evidence for the Standardized Skin Assessment Chart and to Evaluate Changes in Plasma Phenolic Glycolipid-I Over Time for Treatment Monitoring in Multibacillary Leprosy Patients
Page: https://aayushgupta.co/trials/pgl-i-leprosy-treatment-monitoring

## Non-segmental vitiligo: Topical AB1001
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a phase 2 study of topical AB1001 in non-segmental vitiligo, sponsored by Ahammune Biosciences. Status: opens October 2026.
Official title: A Phase II, multicenter, randomized study to evaluate safety and efficacy of topical AB1001 in adult patients with non-segmental vitiligo
Page: https://aayushgupta.co/trials/ab1001-non-segmental-vitiligo

## Hair health in adults: H-Vit hair serum
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for an observational study of h-Vit hair serum in hair health in adults, sponsored by Systopic Laboratories. Status: opens October 2026.
Official title: An Open Label, Prospective, Single Arm Observation Study on H-Vit Hair Serum of Systopic Laboratories Pvt. Ltd. in Adults Looking to Improve Hair Health in Real World Clinical Practice
Page: https://aayushgupta.co/trials/h-vit-hair-serum

## Psoriasis: Guselkumab, subcutaneous
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a phase 4 study of guselkumab, subcutaneous in psoriasis, sponsored by Johnson & Johnson. Status: opens November 2026.
Official title: A Phase IV, Multicenter, Non-comparative, Open-Label Study Evaluating the Safety and Efficacy of Guselkumab Administered Subcutaneously in the Treatment of Indian Patients with Psoriasis (CNTO1959PSO4039)
Page: https://aayushgupta.co/trials/guselkumab-psoriasis-phase-4

## Multibacillary leprosy: Bedaquiline with rifampicin and clofazimine (LIGHT)
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a phase 3 study of bedaquiline with rifampicin and clofazimine (LIGHT) in multibacillary leprosy, sponsored by Johnson & Johnson. Status: under way since January 2025.
Official title: A Phase 3, Multicenter, Open-label, Rater-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Bedaquiline for the Treatment of Multibacillary Leprosy When Combined With Rifampicin and Clofazimine [LIGHT]
Page: https://aayushgupta.co/trials/light-bedaquiline-multibacillary-leprosy

## Atopic dermatitis, alopecia areata and vitiligo: Immuno-dermatology disease registry
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a registry study of immuno-dermatology disease registry in atopic dermatitis, alopecia areata and vitiligo, sponsored by Pfizer. Status: started March 2025, completed.
Official title: An Immuno-Dermatological Disease Registry to Understand the Burden of Atopic Dermatitis (AD), Alopecia Areata (AA), and Vitiligo in Indian Patients
Page: https://aayushgupta.co/trials/immuno-dermatology-disease-registry